Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.35% |
| 2 | Technology | 9.23% |
| 3 | Healthcare | 7.6% |
| 4 | Financials | 5.15% |
| 5 | Consumer Discretionary | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5101
JetBlue
JBLU
$1.85B
| $167K | ﹤0.01% |
36,345
-1,710,449
| -98% | -$11.2M |
|
|
ASAI
5102
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $167K | ﹤0.01% |
+13,687
| New | +$180K |
|
|
GAN
5103
DELISTED
GAN Ltd
GAN
| $167K | ﹤0.01% |
143,579
-20,231
| -12% | -$31.8K |
|
|
CTLP
5104
DELISTED
Cantaloupe
CTLP
| $166K | ﹤0.01% |
+26,624
| New | +$195K |
|
5105
VirTra
VTSI
$34.8M
| $166K | ﹤0.01% |
29,719
-4,540
| -13% | -$30.8K |
|
5106
Aspen Aerogels
ASPN
$434M
| $165K | ﹤0.01% |
19,159
-398,549
| -95% | -$2.83M |
|
5107
Shore Bancshares
SHBI
$770M
| $164K | ﹤0.01% |
+15,542
| New | +$177K |
|
5108
Goldgroup Mining
GORO
$511M
| $162K | ﹤0.01% |
378,677
-169,109
| -31% | -$90.4K |
|
5109
Amplify Junior Silver Miners ETF
SILJ
$4.39B
| $162K | ﹤0.01% |
+19,095
| New | +$180K |
|
|
LSEA
5110
DELISTED
Landsea Homes
LSEA
| $161K | ﹤0.01% |
17,953
-56,440
| -76% | -$566K |
|
5111
Biote Corp
BTMD
$46.7M
| $161K | ﹤0.01% |
31,510
-2,624
| -8% | -$15.5K |
|
5112
Funko
FNKO
$377M
| $161K | ﹤0.01% |
21,046
-71,315
| -77% | -$532K |
|
|
ALLK
5113
DELISTED
Allakos
ALLK
| $161K | ﹤0.01% |
70,903
-1,167,800
| -94% | -$4.34M |
|
5114
AdaptHealth
AHCO
$774M
| $161K | ﹤0.01% |
17,680
-32,672
| -65% | -$392K |
|
5115
CryoPort
CYRX
$839M
| $161K | ﹤0.01% |
11,727
-68,454
| -85% | -$1.01M |
|
|
BFZ
5116
DELISTED
BlackRock CA Municipal Income Trust
BFZ
| $160K | ﹤0.01% |
15,567
-15,567
| -50% | -$176K |
|
|
HLTH
5117
DELISTED
Cue Health Inc. Common Stock
HLTH
| $160K | ﹤0.01% |
361,738
-94,806
| -21% | -$43.2K |
|
|
SHCR
5118
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $160K | ﹤0.01% |
170,079
+66,542
| +64% | +$79.4K |
|
5119
Rocky Brands
RCKY
$339M
| $160K | ﹤0.01% |
+10,862
| New | +$206K |
|
5120
LENSAR
LNSR
$104M
| $158K | ﹤0.01% |
51,223
-4,851
| -9% | -$16.6K |
|
5121
CALL
Taysha Gene Therapies
TSHA
$1.94B
| $158K | ﹤0.01% |
+50,000
| New | +$93.4K |
|
5122
BioAtla
BCAB
$5.23M
| $158K | ﹤0.01% |
1,857
-3,845
| -67% | -$490K |
|
5123
Corvus Pharmaceuticals
CRVS
$1.24B
| $158K | ﹤0.01% |
+108,024
| New | +$228K |
|
5124
Curis
CRIS
$3.64M
| $156K | ﹤0.01% |
1,186
-406
| -26% | -$104K |
|
5125
Immunic
IMUX
$222M
| $156K | ﹤0.01% |
10,622
-83,958
| -89% | -$1.61M |
|
Similar funds
Israel Englander's Q3 2023 Portfolio in Review
As of Q3 2023, Israel Englander held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $6.14B of net new capital in Q3 2023, opening 836 new positions and adding to 2,326 existing holdings. Its largest new stake was Mobileye: 2,953,164 shares worth $123M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $689M trimmed.
- Israel Englander's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Israel Englander's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Israel Englander fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Israel Englander's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Israel Englander opened 836 new positions and closed 834 in Q3 2023.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.